8-K Announcements
6Apr 29, 2026·SEC
Apr 16, 2026·SEC
Mar 19, 2026·SEC
The Allstate Corporation (ALL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
The Allstate Corporation (ALL) stock price & volume — 10-year historical chart
The Allstate Corporation (ALL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
The Allstate Corporation (ALL) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $10.65vs $7.31+45.7% | $14.6Bvs $15.2B-4.0% |
| Q1 2026 | Feb 4, 2026 | $14.31vs $9.83+45.6% | $14.6Bvs $14.5B+0.3% |
| Q4 2025 | Nov 5, 2025 | $11.17vs $7.67+45.6% | $17.1Bvs $15.7B+8.8% |
| Q3 2025 | Jul 30, 2025 | $5.94vs $3.25+82.8% | $16.6Bvs $15.2B+9.3% |
The Allstate Corporation (ALL) competitors in Personal auto and homeowners insurers — business model, growth, and fundamentals comparison
The Allstate Corporation (ALL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
The Allstate Corporation (ALL) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39.41B | 39.81B | 41.1B | 41.69B | 48.68B | 50.62B | 56.59B | 63.52B | 66.46B | 67.14B |
| Revenue Growth % | 5.37% | 1.04% | 3.24% | 1.43% | 16.76% | 3.98% | 11.8% | 12.24% | 4.64% | 3.73% |
| Medical Costs & Claims | 29.24B | 30.63B | 29.96B | 28.66B | 36.65B | 44.94B | 49.42B | 49.02B | 44.37B | 40.4B |
| Medical Cost Ratio % | 74.21% | 76.92% | 72.9% | 68.75% | 75.28% | 88.78% | 87.33% | 77.17% | 66.77% | 60.17% |
| Gross Profit | 10.16B▲ 0% | 9.19B▼ 9.6% | 11.14B▲ 21.2% | 13.03B▲ 16.9% | 12.03B▼ 7.6% | 5.68B▼ 52.8% | 7.17B▲ 26.3% | 14.5B▲ 102.2% | 22.09B▲ 52.3% | 26.74B▲ 0% |
| Gross Margin % | 25.79% | 23.08% | 27.1% | 31.25% | 24.72% | 11.22% | 12.67% | 22.83% | 33.23% | 39.83% |
| Gross Profit Growth % | 26.33% | -9.59% | 21.25% | 16.94% | -7.64% | -52.82% | 26.33% | 102.18% | 52.32% | - |
| Operating Expenses | 5.61B | 6.56B | 5.7B | 6.22B | 5.57B | 7.51B | 7.52B | 8.74B | 8.93B | 11.1B |
| OpEx / Revenue % | 14.25% | 16.48% | 13.86% | 14.93% | 11.43% | 14.83% | 13.29% | 13.76% | 13.44% | 16.53% |
| Depreciation & Amortization | 483M | 511M | 647M | 686M | 1.09B | 847M | 704M | 555M | 482M | 397M |
| Combined Ratio % | 88.46% | 93.4% | 86.76% | 83.69% | 86.72% | 103.62% | 100.61% | 90.93% | 80.2% | 76.7% |
| Operating Income | 4.55B▲ 0% | 2.63B▼ 42.2% | 5.44B▲ 107.1% | 6.8B▲ 25.0% | 6.47B▼ 4.9% | -1.83B▼ 128.3% | -348M▲ 81.0% | 5.76B▲ 1755.5% | 13.16B▲ 128.4% | 15.64B▲ 0% |
| Operating Margin % | 11.54% | 6.6% | 13.24% | 16.31% | 13.28% | -3.62% | -0.61% | 9.07% | 19.8% | 23.3% |
| Operating Income Growth % | 65.18% | -42.23% | 107.12% | 24.97% | -4.94% | -128.3% | 80.98% | 1755.46% | 128.36% | - |
| EBITDA | 5.03B | 3.14B | 6.09B | 7.49B | 7.55B | -983M | 356M | 6.32B | 13.64B | 16.04B |
| EBITDA Margin % | 12.77% | 7.88% | 14.82% | 17.96% | 15.51% | -1.94% | 0.63% | 9.94% | 20.52% | 23.89% |
| Interest Expense | 335M | 332M | 327M | 318M | 330M | 335M | 379M | 400M | 399M | 397M |
| Non-Operating Income | -335M | -332M | -327M | -318M | -330M | -335M | -379M | -400M | -399M | -326M |
| Pretax Income | 4.55B▲ 0% | 2.63B▼ 42.2% | 5.44B▲ 107.1% | 6.8B▲ 25.0% | 6.47B▼ 4.9% | -1.83B▼ 128.3% | -348M▲ 81.0% | 5.76B▲ 1755.5% | 13.16B▲ 128.4% | 15.54B▲ 0% |
| Pretax Margin % | 11.54% | 6.6% | 13.24% | 16.31% | 13.28% | -3.62% | -0.61% | 9.07% | 19.8% | 23.15% |
| Income Tax | 995M | 468M | 1.12B | 1.37B | 1.29B | -488M | -135M | 1.16B | 2.89B | 3.42B |
| Effective Tax Rate % | 21.87% | 17.81% | 20.5% | 20.19% | 19.98% | 26.67% | 38.79% | 20.17% | 21.97% | 21.98% |
| Net Income | 3.55B▲ 0% | 2.16B▼ 39.2% | 4.85B▲ 124.4% | 5.58B▲ 15.0% | 1.61B▼ 71.1% | -1.29B▼ 179.9% | -188M▲ 85.4% | 4.67B▲ 2582.4% | 10.28B▲ 120.3% | 12.14B▲ 0% |
| Net Margin % | 9.02% | 5.43% | 11.79% | 13.37% | 3.32% | -2.55% | -0.33% | 7.35% | 15.47% | 18.09% |
| Net Income Growth % | 89.34% | -39.22% | 124.4% | 15.04% | -71.05% | -179.86% | 85.42% | 2582.45% | 120.31% | 200.32% |
| EPS (Diluted) | 9.35▲ 0% | 6.12▼ 34.5% | 14.03▲ 129.2% | 17.31▲ 23.4% | 17.25▼ 0.3% | -5.03▼ 129.2% | -1.20▲ 76.1% | 16.99▲ 1515.8% | 38.19▲ 124.8% | 46.25▲ 0% |
| EPS Growth % | 100.21% | -34.55% | 129.25% | 23.38% | -0.35% | -129.16% | 76.14% | 1515.83% | 124.78% | 209.56% |
| EPS (Basic) | 9.50 | 6.21 | 14.25 | 17.53 | 17.50 | -5.03 | -1.20 | 17.22 | 38.68 | - |
| Diluted Shares Outstanding | 367.8M | 353.2M | 333.5M | 315.5M | 299.1M | 271.2M | 262.5M | 267.8M | 264.7M | 262.6M |
The Allstate Corporation (ALL) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 112.42B | 112.25B | 119.95B | 125.99B | 99.44B | 97.99B | 103.36B | 111.62B | 119.76B | 123.97B |
| Asset Growth % | 3.51% | -0.15% | 6.86% | 5.03% | -21.07% | -1.46% | 5.48% | 7.99% | 7.29% | 27.74% |
| Total Investment Assets | 6.74B | 7.5B | 8.08B | 4.56B | 8.02B | 8.11B | 8.38B | 9.26B | 83.24B | 4M |
| Long-Term Investments | 4.8B | 4.48B | 3.82B | -2.24B | 4.01B | 3.94B | 3.24B | 4.72B | 78.35B | 300.19B |
| Short-Term Investments | 1.94B | 3.03B | 4.26B | 6.81B | 4.01B | 4.17B | 5.14B | 4.54B | 4.89B | 4.71B |
| Total Current Assets | 17.27B | 19.25B | 20.28B | 20.8B | 23.16B | 23.69B | 24.72B | 24.78B | 26.25B | 32.2B |
| Cash & Equivalents | 617M | 499M | 338M | 311M | 763M | 736M | 722M | 704M | 678M | 697M |
| Receivables | 14.71B | 15.72B | 15.68B | 13.68B | 18.39B | 18.78B | 18.85B | 19.54B | 20.68B | 75.76B |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.08B |
| Goodwill & Intangibles | 2.74B | 3.24B | 3.03B | 2.82B | 4.92B | 4.68B | 4.47B | 4B | 9.84B | 31.22B |
| Goodwill | 2.18B | 2.53B | 2.54B | 2.37B | 3.5B | 3.5B | 3.5B | 3.25B | 3.12B | 3.12B |
| Intangible Assets | 556M | 713M | 481M | 453M | 1.42B | 1.18B | 966M | 754M | 6.72B | 0 |
| PP&E (Net) | 1.07B | 1.04B | 1.15B | 1.06B | 939M | 987M | 859M | 669M | 627M | 606M |
| Other Assets | 86.55B | 84.24B | 91.68B | 103.56B | 66.41B | 64.31B | 69.86B | 77.22B | 4.69B | 7.58B |
| Total Liabilities | 89.87B | 90.94B | 93.95B | 95.77B | 74.31B | 80.63B | 85.73B | 90.25B | 89.17B | 92.39B |
| Total Debt | 6.35B | 6.45B | 6.63B | 7.83B | 7.98B | 7.96B | 7.94B | 8.09B | 7.49B | 7.49B |
| Net Debt | 5.73B | 5.95B | 6.29B | 7.51B | 7.21B | 7.23B | 7.22B | 7.38B | 6.81B | 6.79B |
| Long-Term Debt | 6.35B | 6.45B | 6.63B | 7.83B | 7.98B | 7.96B | 7.94B | 8.09B | 6.94B | 7.49B |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 550M | 0 |
| Total Current Liabilities | 13.11B | 14.89B | 16.06B | 0 | 0 | 0 | 0 | 0 | 70.94B | 84.89B |
| Accounts Payable | 6.47B | 7.16B | 6.91B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.08B | 28.86B |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.31B | 42.79B |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 1000K | 538M |
| Other Liabilities | 69.63B | 69.17B | 70.11B | 87.56B | 65.5B | 72.66B | 77.79B | 82.17B | 11.07B | 0 |
| Total Equity | 22.55B▲ 0% | 21.31B▼ 5.5% | 26B▲ 22.0% | 30.22B▲ 16.2% | 25.13B▼ 16.8% | 17.36B▼ 30.9% | 17.63B▲ 1.5% | 21.37B▲ 21.2% | 30.59B▲ 43.2% | 31.59B▲ 0% |
| Equity Growth % | 9.61% | -5.49% | 21.99% | 16.23% | -16.84% | -30.9% | 1.54% | 21.2% | 43.16% | 147.56% |
| Shareholders Equity | 22.55B | 21.31B | 26B | 30.22B | 25.18B | 17.49B | 17.77B | 21.44B | 30.61B | 31.61B |
| Minority Interest | 0 | 0 | 0 | 0 | -52M | -125M | -140M | -75M | -21M | -20M |
| Retained Earnings | 43.16B | 44.03B | 48.07B | 52.77B | 53.29B | 50.97B | 49.72B | 53.29B | 62.39B | 64.54B |
| Common Stock | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M |
| Accumulated OCI | 303M | 115M | 1.95B | 3.3B | 655M | -2.39B | -700M | -889M | 255M | -292M |
| Return on Equity (ROE) | 16.48% | 9.85% | 20.49% | 19.84% | 5.83% | -6.07% | -1.07% | 23.94% | 39.58% | 42.74% |
| Return on Assets (ROA) | 3.22% | 1.92% | 4.17% | 4.53% | 1.43% | -1.31% | -0.19% | 4.34% | 8.89% | 10.12% |
| Equity / Assets | 20.06% | 18.99% | 21.67% | 23.98% | 25.27% | 17.72% | 17.06% | 19.14% | 25.54% | 25.48% |
| Debt / Equity | 0.28x | 0.30x | 0.26x | 0.26x | 0.32x | 0.46x | 0.45x | 0.38x | 0.24x | 0.24x |
| Book Value per Share | 61.31 | 60.34 | 77.96 | 95.77 | 84.01 | 64.02 | 67.16 | 79.79 | 115.56 | 120.29 |
| Tangible BV per Share | 53.87 | 51.16 | 68.88 | 86.83 | 67.55 | 46.77 | 50.14 | 64.85 | 78.39 | 108.41 |
The Allstate Corporation (ALL) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 4.31B | 5.17B | 5.13B | 5.49B | 5.12B | 5.12B | 4.23B | 8.93B | 10.11B | 10.11B |
| Operating CF Growth % | 8.04% | 19.96% | -0.89% | 7.06% | -6.83% | 0.1% | -17.44% | 111.23% | 13.2% | 138.66% |
| Operating CF / Revenue % | 10.95% | 13% | 12.48% | 13.17% | 10.51% | 10.12% | 7.47% | 14.06% | 15.21% | 15.06% |
| Net Income | 3.19B | 2.16B | 4.85B | 5.58B | 1.57B | -1.36B | -213M | 4.6B | 10.28B | 12.14B |
| Depreciation & Amortization | 483M | 511M | 647M | 686M | 1.09B | 847M | 704M | 555M | 482M | 957M |
| Stock-Based Compensation | 0 | 138M | 120M | 137M | 129M | 102M | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | -120M | -137M | -129M | -102M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 350M | 1.85B | -1.03B | -773M | 2.55B | 5.69B | 309M | 188M | -1.49B | -2.53B |
| Working Capital Changes | 292M | 511M | 666M | 2M | -88M | -53M | 3.43B | 3.59B | 832M | 2.76B |
| Cash from Investing | -1.21B | -1.72B | -2.81B | -3.44B | 510M | -1.73B | -3B | -8.25B | -7.25B | -8.59B |
| Capital Expenditures | -299M | -277M | -433M | -308M | -345M | -420M | -267M | -210M | -228M | -253M |
| Acquisitions | -1.67B | -1.47B | -594M | 86M | -2.42B | -288M | -180M | 5M | 3.04B | 0 |
| Purchase of Investments | -38.76B | -44.36B | -39.88B | -47.01B | -41.91B | -46.51B | -33.27B | 0 | -92.29B | 601M |
| Sale/Maturity of Investments | 39.56B | 44.53B | 38.25B | 43.14B | 44.54B | 45.22B | 30.76B | 0 | 82.22B | 15.14B |
| Other Investing | -46M | -135M | -149M | 653M | 639M | 268M | -37M | -8.05B | 0 | -24.07B |
| Cash from Financing | -2.92B | -3.57B | -2.48B | -2.01B | -5.24B | -3.42B | -1.24B | -697M | -2.88B | -3.46B |
| Dividends Paid | -641M | -748M | -787M | -776M | -999M | -1.03B | -1.03B | -1.08B | -1.15B | -1.17B |
| Share Repurchases | -1.5B | -2.69B | -2.87B | -2.02B | -3.57B | -2.52B | -335M | -2M | -1.23B | -1.75B |
| Stock Issued | 0 | 557M | 1.53B | 63M | 114M | 0 | 0 | 0 | 48M | 13M |
| Debt Issuance (Net) | 0 | 1000K | 1000K | 1000K | -1000K | 0 | -1000K | 1000K | -1000K | -1000K |
| Other Financing | -787M | -793M | -537M | -462M | -349M | 131M | 119M | 239M | 57M | 42M |
| Net Change in Cash | 181M▲ 0% | -118M▼ 165.2% | -161M▼ 36.4% | 39M▲ 124.2% | 452M▲ 1059.0% | -27M▼ 106.0% | -14M▲ 48.1% | -18M▼ 28.6% | -26M▼ 44.4% | -143M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 66M | 0 | 0 | 0 | 0 | 201M |
| Cash at Beginning | 436M | 617M | 499M | 338M | 311M | 763M | 736M | 722M | 704M | 678M |
| Cash at End | 617M | 499M | 338M | 377M | 763M | 736M | 722M | 704M | 678M | 697M |
| Free Cash Flow | 4.01B▲ 0% | 4.9B▲ 22.0% | 4.7B▼ 4.1% | 5.18B▲ 10.4% | 4.77B▼ 7.9% | 4.7B▼ 1.5% | 3.96B▼ 15.7% | 8.72B▲ 120.2% | 9.88B▲ 13.3% | 11.53B▲ 0% |
| FCF Growth % | 9.1% | 21.99% | -4.12% | 10.37% | -7.95% | -1.47% | -15.74% | 120.17% | 13.31% | 28.59% |
| FCF Margin % | 10.19% | 12.3% | 11.42% | 12.43% | 9.8% | 9.29% | 7% | 13.73% | 14.87% | 17.18% |
| FCF per Share | 10.92 | 13.87 | 14.08 | 16.43 | 15.95 | 17.33 | 15.09 | 32.57 | 37.33 | 37.33 |
The Allstate Corporation (ALL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 88.46% | 93.4% | 86.76% | 83.69% | 86.72% | 103.62% | 100.61% | 90.93% | 80.2% | 76.7% |
| Medical Cost Ratio | 74.21% | 76.92% | 72.9% | 68.75% | 75.28% | 88.78% | 87.33% | 77.17% | 66.77% | 60.17% |
| Return on Equity (ROE) | 16.48% | 9.85% | 20.49% | 19.84% | 5.83% | -6.07% | -1.07% | 23.94% | 39.58% | 42.74% |
| Return on Assets (ROA) | 3.22% | 1.92% | 4.17% | 4.53% | 1.43% | -1.31% | -0.19% | 4.34% | 8.89% | 10.12% |
| Equity / Assets | 20.06% | 18.99% | 21.67% | 23.98% | 25.27% | 17.72% | 17.06% | 19.14% | 25.54% | 25.48% |
| Book Value / Share | 61.31 | 60.34 | 77.96 | 95.77 | 84.01 | 64.02 | 67.16 | 79.79 | 115.56 | 120.29 |
| Debt / Equity | 0.28x | 0.30x | 0.26x | 0.26x | 0.32x | 0.46x | 0.45x | 0.38x | 0.24x | 0.24x |
| Revenue Growth | 5.37% | 1.04% | 3.24% | 1.43% | 16.76% | 3.98% | 11.8% | 12.24% | 4.64% | 3.73% |
The Allstate Corporation (ALL) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 29, 2026·SEC
Apr 16, 2026·SEC
Mar 19, 2026·SEC
The Allstate Corporation (ALL) stock FAQ — growth, dividends, profitability & financials explained
The Allstate Corporation (ALL) grew revenue by 4.6% over the past year. Growth has been modest.
Yes, The Allstate Corporation (ALL) is profitable, generating $12.14B in net income for fiscal year 2025 (15.5% net margin).
Yes, The Allstate Corporation (ALL) pays a dividend with a yield of 1.80%. This makes it attractive for income-focused investors.
The Allstate Corporation (ALL) has a return on equity (ROE) of 39.6%. This is excellent, indicating efficient use of shareholder capital.
The Allstate Corporation (ALL) has a combined ratio of 80.2%. A ratio below 100% indicates underwriting profitability.
The Allstate Corporation (ALL) financial analysis — history, returns, DCA and operating performance tools
Analyst verdict, bull/bear case, risk factors and peer comparison
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates